Key Takeaways NGS, ASC, ATGE, and RGCO show strong net margins and upward EPS revisions for fiscal 2025. All four stocks have Zacks Ranks of 1 or 2 and VGM Scores of A or B, indicating solid upside potential. Each company has an impressive track record of beating earnings estimates.The primary purpose of a business is to generate profits that can be reinvested in expansion or utilized for rewarding shareholders. The net profit margin is an effective tool to measure the profits reaped by a business.A highe ...

For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Adtalem Global Education (ATGE) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Discretionary sector should help us answer this question.Adtalem Global Education is one of 255 companies in the Consumer Discretionary group. The Consumer Discretionary group currently sits ...

Investors interested in Consumer Discretionary stocks should always be looking to find the best-performing companies in the group. Adtalem Global Education (ATGE) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Consumer Discretionary peers, we might be able to answer that question.Adtalem Global Education is one of 255 individual stocks in th ...

Adtalem Global Education (ATGE) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 All right. We're gonna get started. Good afternoon. My name is Steven Pollock, the Baird research analyst covering post secondary education here at Baird. Our next presenting company is Adtalem Global Education. They operate five healthcare focused institutions in The U. S. With more than 80,000 students currently enrolled. Here from the company, we have CEO, Steve Beard. We also have in the audience CFO, Bob Phelan and Head ...

Core Viewpoint - Investors are evaluating the value opportunities presented by Adtalem Global Education (ATGE) and Universal Technical Institute (UTI) in the current market [1] Group 1: Zacks Rank and Value Scores - Both ATGE and UTI currently hold a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and improving earnings outlooks [3] - The Zacks Rank is a strategy that targets companies with favorable earnings estimate trends, while the Style Scores assess companies based on specific traits [2] Group 2: Valuation Metrics - ATGE has a forward P/E ratio of 19.90, while UTI has a higher forward P/E of 33.82 [5] - ATGE's PEG ratio is 1.33, which is more favorable compared to UTI's PEG ratio of 2.25, indicating better expected EPS growth relative to its valuation [5] - ATGE's P/B ratio stands at 3.37, significantly lower than UTI's P/B of 6.62, suggesting ATGE is more undervalued based on its book value [6] Group 3: Overall Value Assessment - Based on various valuation metrics, ATGE is assigned a Value grade of B, while UTI receives a Value grade of C, indicating that ATGE is currently the superior value option [6]

Adtalem Global Education Inc. (ATGE) stock’s performance has been impressive in the year-to-date (YTD) period, with a 42.6% rise compared with the Zacks Schools industry’s 8.7% growth. It has also outperformed the Zacks Consumer-Discretionary sector's rise of 3% and the S&P 500 index’s 1.1% decline during the same period.This healthcare education provider and workforce solutions innovator is benefiting from solid enrollment growth, strategic initiatives and the efficient execution of its Growth with Purpose ...

Core Insights - American Public Education, Inc. (APEI) reported strong first-quarter 2025 results, with adjusted earnings and total revenues exceeding expectations and showing year-over-year growth [1][2] - The performance was primarily driven by contributions from Rasmussen University (RU), American Public University System (APUS), and Hondros College of Nursing (HCN), while the Graduate School (GSUSA) segment experienced a revenue decline [1][2] Financial Performance - APEI's adjusted earnings per share (EPS) reached 41 cents, significantly surpassing the Zacks Consensus Estimate of 15 cents by 173.3%, compared to a loss of six cents per share in the same quarter last year [3] - Total revenues amounted to $164.6 million, exceeding the consensus mark of $162 million by 1.6% and growing 6.6% year over year, supported by net course registration growth and tuition increases [4] - Total costs and expenses rose 2% year over year to $152.3 million, driven by a 3.5% increase in instructional costs and an 8.5% rise in selling and promotional expenses [4] - Adjusted EBITDA increased by 24% year over year to $21.2 million, with an adjusted EBITDA margin of 13%, expanding 200 basis points from 11% [5] Segment Performance - APUS reported revenues of $83.9 million, a 4.1% increase from $80.7 million year over year, driven by net course registrations and tuition increases [6] - RU's revenues grew 11.5% year over year to $59.3 million, attributed to enrollment growth and tuition hikes, with total student enrollment increasing 7.4% to 14,500 [7][8] - HCN's revenues rose 7.5% year over year to $17.7 million, supported by student enrollment growth, although it reported a negative EBITDA margin of 1% [8][9] - GSUSA's revenues declined 11.9% year over year to $3.7 million, with a negative EBITDA margin of 57% [10] Cash and Debt Position - As of March 31, 2025, APEI had cash, cash equivalents, and restricted cash of $187.5 million, up from $158.9 million at the end of 2024 [11] - Net long-term debt slightly increased to $93.7 million from $93.4 million at the end of 2024 [11] Guidance and Outlook - For Q2 2025, APEI expects total revenues to increase by 4-5% year over year to $160-$162 million, with a projected loss per share between 13 cents and four cents [12] - Adjusted EBITDA for Q2 is anticipated to be between $11.5 million and $14 million, reflecting year-over-year growth of 6% to 28% [12] - The company revised its 2025 guidance, expecting total revenues to grow 4-6% year over year to $650-$660 million, with adjusted EBITDA projected between $77 million and $87 million [14]

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style ...

Adtalem Global Education Inc. (ATGE) posted impressive third-quarter fiscal 2025 results, wherein adjusted earnings and revenues topped the Zacks Consensus Estimate and increased year over year.The quarter’s performance was driven by robust performance across all the company’s reportable segments, resulting in top-line growth. The segments’ performances were mainly backed by increased enrollment and higher tuition rates. Also, ATGE’s focus on strategic investments to boost student experience is boding well. ...

Q3 2025 Performance Highlights - Adtalem's revenue reached $466.1 million, a 12.9% increase compared to the prior year[16] - Adjusted EBITDA margin was 27.4%, a 150 bps increase compared to the prior year[17] - Adjusted EPS was $1.92, a 28.0% increase compared to the prior year[17] - Total enrollment grew by 9.8% year-over-year[15] Segment Performance - Chamberlain's revenue increased by 13.1% to $192.6 million, with a 6.8% increase in total enrollment[30] - Walden's revenue increased by 18.5% to $178.4 million, with a 13.5% increase in total enrollment[35] - Medical & Veterinary revenue increased by 3.6% to $95.0 million, with a 1.2% increase in total enrollment[40] Cash Flow and Capital Allocation - Trailing twelve months free cash flow was $287 million[21] - The company repaid $100 million of outstanding Term Loan B balance on January 17, 2025[21] - A new $150 million share repurchase authorization was approved through May 2028[21] FY 2025 Guidance - The company raised its revenue outlook to $1.760 billion - $1.775 billion[46] - The company raised its Adjusted EPS outlook to $6.40 - $6.60[46]